Carlos Arturo Alvarez-Moreno is a Specialist in Infectious Diseases at the National University and a Specialist in Tropical and Travel Medicine at the University of Alabama-Cayetano Heredia. He has a Master’s degree in Clinical Epidemiology from the Pontificia Universidad Javeriana, a Master’s degree in HIV/AIDS from the Rey Juan Carlos University, Spain, and a doctorate in Biological Sciences from the University of Nantes, France. He is currently a full professor in Infectious Diseases and Tropical Medicine at the Department of Internal Medicine of the Faculty of Medicine of the National University and Vice President of Health at Clínica Colsanitas. He belongs to several scientific societies and has received international recognition, such as being considered an honorary member of the American Society of Infectious Diseases (FIDSA), and Ambassador for Latin America of the American Society of Hospital Epidemiology (SHEA). Since 2011, he has been a member of the National Academy of Medicine of Colombia. He is involved in research projects related to the epidemiology of antimicrobial resistance, control of infections associated with health care, HIV/AIDS infection, and clinical trials related to antimicrobials. He is the co-author of more than 20 technical reports, 100 publications in indexed journals (H factor: 26 in SCOPUS), as well as more than 50 book chapters.
Evaldo Stanislau Affonso De Araújo has a degree in Medicine from the Faculty of Medical Sciences of Santos (1991), a Master's degree in Infectious and Parasitic Diseases from the Faculty of Medicine of the University of São Paulo (2000), and a Ph.D. in Infectious and Parasitic Diseases from the Faculty of Medicine of the University of São Paulo (2005). Currently, he is a Professor of Medicine at São Judas Tadeu University and an Ambassador at Inspirali Education for Infectious Diseases, One Health, and Precision Medicine. He is also the head of Academic Research for Inspirali and an assistant doctor at the Infectious Diseases Division at Hospital das Clinicas University of São Paulo. He has experience in the area of medicine, with an emphasis on infectious and parasitic diseases, working mainly in the area of viral hepatitis and hospital infections, as well as experience in the areas of health management and the third sector, and consultancy to multinational bodies (WHO), governments (SMS Santos, SES SP, and the Ministry of Health) and Scientific Societies (SPI and SBI).
Elsa Baumeister received a degree in Biochemistry from the UBA and a Master's in Molecular Microbiology from UNSAM. In 2012, she was appointed Head of the Respiratory Viruses Service of ANLIS, Influenza Center and Measles Laboratory for the WHO. She organized the Influenza A (H1N1) Laboratory in 2009 and the COVID-19 Reference Laboratory for the country and the WHO in 2020. She early alerted the Health authorities about the emergency of SARS-CoV-2 in China. She organized the first National Molecular Diagnostic Network based on real-time PCR that allowed the decentralization of the diagnosis of Influenza A in 2009 and COVID-19 in 2020 to all provinces. She participated in the development of the horse antiserum for COVID-19, the validation of kits, reagents, and alternative samples for the diagnosis of SARS-CoV-2 in the study of viral variants, in trials with vaccine prototypes, and in studies of the effectiveness of vaccines for COVID-19. She directs the Chair of Clinical Virology at UNLP and the Master's degree in Molecular Microbiology at UNSAM. She was a visiting researcher at the US CDC and at the Osvaldo Cruz Institute in Brazil. She has published 65 scientific works and 9 book chapters, and has received 11 awards.
Pablo Tsukayama obtained his Ph.D. in Molecular Microbiology at Washington University in St. Louis, working with Prof Gautam Dantas. Later, as a Chevening Scholar, he completed an MSc in Public Health in Developing Countries at the London School of Hygiene and Tropical Medicine. In 2017, he returned to Peru as an assistant professor of microbiology at Universidad Peruana Cayetano Heredia, where he started his undergraduate training 15 years earlier. His research interests lie at the interface of genomics, public health, and infectious disease epidemiology, with a focus on bacterial pathogens affecting Peruvian populations.
In the last 15 years, after finishing medical school at Universidad Peruana Cayetano Heredia (UPCH), Cesar Ugarte-Gil worked in Tuberculosis (TB) research, participating at the Institute of Tropical Medicine Alexander von Humboldt (IMTAvH) at the UPCH in several TB diagnostic and epidemiological studies. He holds an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine and a Ph.D. in Global Diseases Epidemiology and Control from the Johns Hopkins Bloomberg School of Public Health. His main research interests in Tuberculosis are non-communicable comorbidities (including diabetes mellitus and depression) and diagnostic trials. Other research interests include HIV/AIDS, tropical diseases, and COVID-19.
